Production (Stage)
The Cigna Group
CI
$315.99
$3.311.06%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 254.45B | 246.15B | 231.60B | 216.72B | 204.82B |
| Total Other Revenue | 921.00M | 973.00M | 986.00M | 1.22B | 1.18B |
| Total Revenue | 255.37B | 247.12B | 232.59B | 217.94B | 206.00B |
| Cost of Revenue | 229.18B | 221.16B | 206.51B | 191.99B | 180.45B |
| Gross Profit | 26.19B | 25.96B | 26.08B | 25.96B | 25.55B |
| SG&A Expenses | 14.69B | 14.56B | 14.57B | 14.63B | 14.44B |
| Depreciation & Amortization | 1.70B | 1.70B | 1.73B | 1.75B | 1.78B |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 245.58B | 237.42B | 222.81B | 208.36B | 196.68B |
| Operating Income | 9.79B | 9.70B | 9.78B | 9.58B | 9.32B |
| Income Before Tax | 6.84B | 5.27B | 3.45B | 4.10B | 3.99B |
| Income Tax Expenses | 1.44B | 1.49B | 99.00M | 123.00M | 137.00M |
| Earnings from Continuing Operations | 5.40K | 3.78K | 3.35K | 3.97K | 3.85K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -365.00M | -344.00M | -310.00M | -265.00M | -234.00M |
| Net Income | 5.03B | 3.43B | 3.04B | 3.71B | 3.62B |
| EBIT | 9.79B | 9.70B | 9.78B | 9.58B | 9.32B |
| EBITDA | 12.50B | 12.48B | 12.67B | 12.59B | 12.35B |
| EPS Basic | 18.17 | 12.32 | 10.69 | 12.82 | 12.27 |
| Normalized Basic EPS | 17.42 | 17.15 | 17.19 | 16.68 | 16.09 |
| EPS Diluted | 18.05 | 12.23 | 10.60 | 12.71 | 12.18 |
| Normalized Diluted EPS | 17.30 | 17.05 | 17.09 | 16.59 | 16.02 |
| Average Basic Shares Outstanding | 1.11B | 1.12B | 1.14B | 1.16B | 1.17B |
| Average Diluted Shares Outstanding | 1.12B | 1.13B | 1.15B | 1.16B | 1.18B |
| Dividend Per Share | 5.71 | 5.60 | 5.43 | 5.26 | 5.09 |
| Payout Ratio | 31.35% | 45.63% | 50.71% | 40.80% | 40.97% |